Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma

Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma

Show other versions (1)

Background/Aims Omalizumab is the first biologic known to be effective in patients with severe allergic asthma. Methods This study was conducted as a multicenter, single-group, open trial to evaluate the improvement in the quality of life with the additional administration of omalizumab for 24 weeks...

Full description

Bibliographic Details
Main Authors: Jae-Woo Jung, Hae-Sim Park, Choon-Sik Park, Sang-Heon Cho, Inseon S. Choi, Hee-Bom Moon, Soon Seog Kwon, Ho Joo Yoon, Jung Won Park, Jong-Myung Lee, Dong-Chull Choi, Byoung Whui Choi
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2021-07-01
Series:The Korean Journal of Internal Medicine
Subjects:
omalizumab
quality of life
republic of korea
asthma
prospective studies
Online Access:http://www.kjim.org/upload/pdf/kjim-2020-549.pdf

Internet

http://www.kjim.org/upload/pdf/kjim-2020-549.pdf

Similar Items